Multimodal cell communication networks nominate immunotherapies for RCC subgroups with discrete T cell recruitment or expansion
Renal cell carcinoma (RCC) is amongst the most immune-infiltrated solid tumours, but only a small subset of patients achieves durable response to immune checkpoint blockade therapy. Efforts to characterize the immune microenvironment and molecular regulators responsible for treatment responses have explored numerous facets of disease biology using compartmentalized genomics, transcriptomics, and…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.
